Computational enzyme design for a greener future.
ZYMVOL, a pioneering biotechnology company, has successfully raised $3 million in its latest funding round. This investment aims to accelerate the company’s efforts in computational enzyme discovery and design. As the demand for innovative solutions in biotechnology increases, ZYMVOL is poised to make a substantial impact in the field.
The funding round attracted a diverse group of investors, highlighting their confidence in ZYMVOL’s mission. The company will utilize this capital to enhance its proprietary technology platform, which s
Leave a Reply